Royal Bank Of Canada Lowers Humana Inc. (HUM) Price Target to $217.00
Humana Inc. (NYSE:HUM) had its price target reduced by analysts at Royal Bank Of Canada from $222.00 to $217.00 in a research note issued on Thursday. The firm currently has a “sector perform” rating on the insurance provider’s stock. Royal Bank Of Canada’s price objective suggests a potential upside of 28.83% from the company’s previous close.
A number of other analysts have also recently commented on the stock. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $198.00 target price on the stock in a report on Tuesday, October 4th. Evercore ISI assumed coverage on shares of Humana in a report on Thursday, September 22nd. They set a “buy” rating and a $200.00 target price on the stock. Credit Suisse Group AG restated a “hold” rating and set a $188.00 target price on shares of Humana in a report on Tuesday, September 13th. Argus restated a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. Finally, Cantor Fitzgerald restated a “buy” rating on shares of Humana in a report on Monday, August 8th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Humana currently has an average rating of “Buy” and an average price target of $200.50.
Humana (NYSE:HUM) opened at 168.44 on Thursday. The company has a market cap of $25.11 billion, a price-to-earnings ratio of 25.88 and a beta of 0.90. The firm’s 50-day moving average is $176.40 and its 200-day moving average is $175.87. Humana has a 12 month low of $150.00 and a 12 month high of $191.65.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/13/royal-bank-of-canada-lowers-humana-inc-hum-price-target-to-217-00.html
Humana (NYSE:HUM) last announced its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, beating the Zacks’ consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The firm had revenue of $14 billion for the quarter, compared to analysts’ expectations of $13.59 billion. During the same quarter in the previous year, the business posted $1.67 EPS. The company’s quarterly revenue was up 2.0% on a year-over-year basis. On average, analysts anticipate that Humana will post $9.24 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be paid a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.69%. Humana’s dividend payout ratio (DPR) is presently 18.18%.
Several hedge funds and other institutional investors have recently made changes to their positions in HUM. Prudential PLC increased its position in shares of Humana by 3.0% in the first quarter. Prudential PLC now owns 8,866 shares of the insurance provider’s stock worth $1,622,000 after buying an additional 259 shares during the period. Geode Capital Management LLC increased its position in shares of Humana by 2.3% in the first quarter. Geode Capital Management LLC now owns 1,166,562 shares of the insurance provider’s stock worth $212,975,000 after buying an additional 25,947 shares during the period. Loomis Sayles & Co. L P increased its position in shares of Humana by 52.6% in the first quarter. Loomis Sayles & Co. L P now owns 300,004 shares of the insurance provider’s stock worth $54,886,000 after buying an additional 103,370 shares during the period. Nicholas Investment Partners LP increased its position in shares of Humana by 45.1% in the first quarter. Nicholas Investment Partners LP now owns 6,983 shares of the insurance provider’s stock worth $1,278,000 after buying an additional 2,170 shares during the period. Finally, Pictet Asset Management Ltd. increased its position in shares of Humana by 2.2% in the first quarter. Pictet Asset Management Ltd. now owns 169,409 shares of the insurance provider’s stock worth $29,981,000 after buying an additional 3,610 shares during the period. Institutional investors own 93.24% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.